Canopy Growth

(NYSE: CGC)
Healthcare  |  Drug Manufacturers—Specialty & Generic
14.58 -0.0188 -0.13%
Stock Price | March 27, 2020, 3:59 p.m.
11 Followers
Bid: 14.38
Ask: 15.65
Prev. Close: 14.6
52 Week Low: 9.0
52 Week High: 52.74
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more Read less

Recently Viewed Tickers

Premium Changes to the Global Cannabis Stock Index for April 2020

3 Comments
Yesterday

Premium Cannabis Stocks Review - Weekend Edition 03/30/20

13 Comments
Yesterday

Premium Cannabis Sub-Sector Review - 03/27/20

10 Comments
Yesterday

Premium Cannabis Stocks Review - Pre-Market Edition 03/26/20

6 Comments
4 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 03/24/20

2 Comments
6 days ago

Premium Cannabis Stocks Review - AM Edition 03/23/20

35 Comments
6 days ago

Premium Cannabis Stocks Review - Weekend Edition 03/23/20

13 Comments
1 week ago

Premium Weekly Review 03/20/20

2 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 03/19/20

41 Comments
1 week ago

Premium Toking Tuesday Chat - 03/17/20

2 Comments
1 week ago